vidarabine has been researched along with Endocarditis, Loeffler in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azzi, N; De Ville, A; Dedeken, L; Devalck, C; Ferster, A; Huybrechts, S; Massin, M; Rooze, S; Roufosse, F; Sanoussi, I; Sauvage, D | 1 |
| Afanasyev, BV; Anagnostopoulos, A; Andreeff, M; Champlin, RE; Mikhailova, N; O'Brien, S; Pankratova, OS; Rondón, G; Semenova, EV; Ueno, NT; Zaritskey, AY; Zoubarovskaya, LS | 1 |
1 review(s) available for vidarabine and Endocarditis, Loeffler
| Article | Year |
|---|---|
Successful non-myeloablative allogeneic transplantation for treatment of idiopathic hypereosinophilic syndrome.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Hematopoietic Stem Cell Transplantation; Humans; Hypereosinophilic Syndrome; Male; Melphalan; Transplantation Chimera; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine | 2002 |
1 other study(ies) available for vidarabine and Endocarditis, Loeffler
| Article | Year |
|---|---|
Treatment-refractory hypereosinophilic syndrome responding to fludarabine in a 12-year-old boy.
Topics: Bone Marrow; Child; Combined Modality Therapy; Humans; Hypereosinophilic Syndrome; Male; Treatment Outcome; Vidarabine | 2015 |